In the nondisease state, APP produces nonamyloidogenic Aβ products by α-secretase, but in the AD brain, Aβ is produced from APP by the sequential enzymatic actions of β-site APP cleaving enzymes 1 (BACE-1, a β-secretase) and γ-secretase [20, 21]. Here, BACE1 is linked to Alzheimer disease.